All In MedTech

FDA Clearance Tracker · P050034

IMPLANTABLE MINIATURE TELESCOPE (IMT)

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Jul 1, 2010 (this decision)Source: openFDAMethods & limitations

PMAFirst of its product code

The decision

FDA number
P050034
Device name
IMPLANTABLE MINIATURE TELESCOPE (IMT)
Applicant location
Far Hills, NJ
Received
Sep 9, 2005
Decided
Jul 1, 2010
Decision
Approved
Expedited review
Yes, flagged as expedited in FDA's record.
Supplements
20 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III
Specialty
Ophthalmology

Every decision under product code NCJ

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE IMT MODELS WIDE ANGLE 2.2X AND WIDE ANGLE 2.7X. THIS DEVICE IS INDICATED FOR MONOCULARIMPLANTATION TO IMPROVE VISION IN PATIENTS GREATER THAN OR EQUAL TO 75 YEARS OF AGE WITH STABLESEVERE TO PROFOUND VISION IMPAIRMENT (BEST CORRECTED DISTANCE VISUAL ACUITY 20/160 TO 20/800) CAUSED BY BILATERAL CENTRAL SCOTOMAS ASSOCIATED WITH END-STAGE AGE-RELATED MACULAR DEGENERATION. PATIENTS MUST:1) HAVE RETINAL FINDINGS OF GEOGRAPHIC ATROPHY OR DISCIFORM SCAR WITH FOVEAL INVOLVEMENT, ASDETERMINED BY FLUORESCEIN ANGIOGRAPHY;2) HAVE EVIDENCE OF VISUALLY SIGNIFICANT CATARACT (> GRADE 2);3) AGREE TO UNDERGO PRE-SURGERY TRAINING AND ASSESSMENT (TYPICALLY 2 TO 4 SESSIONS) WITH LOWVISION SPECIALISTS (OPTOMETRIST OR OCCUPATIONAL THERAPIST) IN THE USE OF AN EXTERNALTELESCOPE SUFFICIENT FOR PATIENT ASSESSMENT AND FOR THE PATIENT TO MAKE AN INFORMEDDECISION;4) ACHIEVE AT LEAST A 5-LETTER IMPROVEMENT ON THE ETDRS CHART WITH AN EXTERNAL TELESCOPE;5) HAVE ADEQUATE PERIPHERAL VISION IN THE EYE NOT SCHEDULED FOR SURGERY; AND6) AGREE TO PARTICIPATE IN POSTOPERATIVE VISUAL TRAINING WITH A LOW VISION SPECIALIST.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code NCJ (Telescope, implantable, miniature).
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Samsara Vision, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.